Portfolio

To date our members have invested in the following companies:

 

Dxcover Limited (formerly Clinspec Diagnostics) has developed a simple to use test for early diagnosis of cancer. This allows same-day detection and grading of a broad range of diseases. Alba Equity members participated in the seed funding round in 2019 when the company was spun-out from the University of Strathclyde and in the company’s second round fundraise of £3.5m in 2020.

 

GM Flow was formed in 2014 to offer Adjusta-Cone® as the world’s first fully adjustable, differential pressure cone meter for natural gas measurement. They have since developed further patented meters for gas measurement and diversified into the hydrogen industry. Alba Equity led the company’s first investment round in January 2020, raising a significant six-figure sum and a second round was completed in early 2022 alongside a new trade investor.

 

Trojan have developed a patented ‘flat and flush’ charging point and related technology for on-street electric vehicle charging. They installed their first live charging points in Camden in London in 2021 and secured a major contract with Barnet Council in 2022. Alba Equity participated in the company’s initial £1m equity raise in June 2020 and increased our participation in a further £2m+ fundraise in 2021.  We also participated as part of a total funding round of £10m+ in 2022, which included £9m from the Scottish National Investment Bank.

 

Founded in 2017, Cumulus is the first oncology drug development accelerator in Europe.  Founded by a team with in-depth oncology expertise and proven commercial success, Cumulus brings a powerful ‘hub and spoke’ approach to the European market for the first time.  Alba Equity participated in the company’s £1.7m funding round in June 2020, as well as in a second round of funding of £4.1m concluded in February 2022.

 

Pneumowave (formerly Altair Medical) is a digital health company developing a wearable sensor that aims to radically improve patient outcomes in numerous clinical situations.  Pneumowave’s technology is able to accurately monitor very large numbers of patients in any location simultaneously.  Alba Equity led the investment syndicate in the company’s first external funding round totalling £2.25m in April 2021 and following excellent progress with ongoing trials, in a follow-on round in 2022.

 

Founded in 2018, Sentinel Subsea Limited has developed a unique method of monitoring and managing the integrity of subsea wells and wellheads for the oil and gas industry, providing environmental assurance on a continual basis that no other solution can offer.  Alba Equity led an investment of over £0.5m in 2021 to support the commercialisation of the company’s offering, as well as continued development into complimentary sectors such as carbon capture and storage.

 

Based in Edinburgh, Carcinotech manufacture 3D printed mini tumours developed from patient-specific stem cells, primary cells and established cell lines.  Alba Equity participated in the company’s £1.6m funding round in April 2022 to fund acceleration of commercialisation and international market expansion.

 

Leap Automation provide solutions to automate end of line packing for clients in the food and drink industry.  Following a round of investment by private individuals in 2021, Alba Equity members invested in a £1m+ funding round in September 2022 to provide support for expansion of the company’s client base and an increase in production capacity.

 

 

ITZA Media is building a digital learning platform that builds the intrinsic value of self-directed online learning, empowering teens to become confident, independent learners.  Alba Equity members invested in December 2023 alongside existing investors to fund the ongoing development of the platform and building capacity to help drive commercial revenues.